Abbott Laboratories
ABT
#90
Rank
NZ$327.61 B
Marketcap
NZ$188.23
Share price
0.28%
Change (1 day)
-18.04%
Change (1 year)
Categories

Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.

EPS for Abbott Laboratories (ABT)

EPS in 2025 (TTM): NZ$6.41

According to Abbott Laboratories's latest financial reports the company's current EPS (TTM) is NZ$6.27. In 2024 the company made an earnings per share (EPS) of NZ$12.93 an increase over its 2023 EPS that were of NZ$5.52.

EPS history for Abbott Laboratories from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$6.41-50.42%
2024NZ$12.93134.51%
2023NZ$5.52-23.23%
2022NZ$7.187.5%
2021NZ$6.6857.41%
2020NZ$4.2521.54%
2019NZ$3.4954.75%
2018NZ$2.26389.07%
2017NZ$0.46-71.01%
2016NZ$1.59-68.01%
2015NZ$4.9896.13%
2014NZ$2.54-8.64%
2013NZ$2.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.63 197.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.31 96.32%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.28-63.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.21-1.04%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
NZ$29.73 374.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$3.28-47.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
NZ$4.07-35.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$4.97-20.78%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$8.95 42.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$6.30 0.51%๐Ÿ‡ฌ๐Ÿ‡ง UK